[Presence of HTLV-I antibodies in patients with sexually transmitted diseases].
The prevalence of human T-lymphotropic type I virus (HTLV-I) among patients with sexually-transmitted diseases is studied in Russia. Primary screening of antibodies to HTLV-I in the sera was carried out by enzyme immunoassay with recombinant gag and env HTLV-I-specific antigens synthesized in Escherichia coli. For secondary screening, Serodia HTLV-I and Vironostika Microelisa System kits were used. None of the 1271 serum samples collected in the towns of Perm and Ekaterinburg was HTLV-I-positive. This indicates a lower, in comparison with other European countries, level of infection with this virus, at least in this region of Russia. Testing of sera from 79 HIV-infected patients revealed none infected with HTLV-I.
M N
MN
Sankov
M R
MR
Bobkova
V A
VA
Terskikh
T A
TA
Khanina
S Ia
SIa
Zverev
V I
VI
Frizen
E V
EV
Buravtsova
V V
VV
Pokrovskiĭ
A F
AF
Bobkov
D K
DK
L'vov
D015481:HTLV-I Antibodies / Q000097:blood*; D015490:HTLV-I Infections / Q000150:complications / Q000453:epidemiology; D006801:Humans; D007124:Immunoenzyme Techniques; D012426:Russia / Q000453:epidemiology; D012749:Sexually Transmitted Diseases / Q000150:complications / Q000276:immunology*
D015481:HTLV-I Antibodies